Global Retirement Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408 Buy
+11
New +$334 ﹤0.01% 4321
2025
Q4
$299 Buy
+11
New +$386 ﹤0.01% 4071
2020
Q2
Sell
-200
Closed -$7K 1597
2020
Q1
$7K Hold
200
﹤0.01% 1121
2019
Q4
$10K Hold
200
﹤0.01% 1142
2019
Q3
$6K Hold
200
﹤0.01% 1230
2019
Q2
$10K Hold
200
﹤0.01% 1097
2019
Q1
$13K Hold
200
﹤0.01% 968
2018
Q4
$9K Sell
200
-91
-31% -$5.62K ﹤0.01% 991
2018
Q3
$22K Hold
291
0.01% 773
2018
Q2
$25K Buy
291
+91
+46% +$7.94K 0.01% 725
2018
Q1
$16K Buy
+200
New +$15.5K ﹤0.01% 815

Other funds holding AGIO

Global Retirement Partners's AGIO Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 11 shares worth $408. The stake represents ﹤0.01% of the portfolio and ranks #4321 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AGIO as recently as Q4 2025.

Global Retirement Partners first reported a position in AGIO in Q1 2018 and has held it in 11 quarters since. The position peaked at $25K in Q2 2018. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Global Retirement Partners held 11 shares of Agios Pharmaceuticals worth $408 as of Q2 2026.
  • Agios Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4321 holding.
  • Global Retirement Partners first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 11 quarters since.
  • Global Retirement Partners's Agios Pharmaceuticals position peaked at $25K in Q2 2018.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.